Associated Papers
Single-nucleotide polymorphisms in DNA repair genes ERCC, XRCC, and MGMT and implications in glioblastoma: a pathway analysis and structural dynamics study.
Afshar Y et al.
Journal of Biomolecular Structure & Dynamics, 2025
Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtype.
Zhu Y et al.
Brain Pathology (zurich, Switzerland), 2025
Identifying active and inhibitor-resistant MGMT variants for gene therapy.
Cheong A et al.
American Journal of Human Genetics, 2025
Evaluation of mutations on O6-methylguanine methyl transferase structure and its interactions: molecular dynamics simulation study.
Gharouni M et al.
Journal of Biomolecular Structure & Dynamics, 2025
Integrative Computational Analysis of Common EXO5 Haplotypes: Impact on Protein Dynamics, Genome Stability, and Cancer Progression.
Mazza F et al.
Journal of Chemical Information and Modeling, 2025
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J et al.
Journal of Neuro-oncology, 2024
Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet chemotherapy.
Singh S et al.
Journal of Biomolecular Structure & Dynamics, 2024
New molecular prognostic factors of adult diffuse lower-grade gliomas in post-2016 molecular era: a retrospective analysis from single center.
Wang Q et al.
British Journal of Neurosurgery, 2023
Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method.
Capar Gorali B et al.
Cellular and Molecular Biology (noisy-le-grand, France), 2023
Genetic and epigenetic alterations in MGMT gene and correlation with concomitant chemoradiotherapy (CRT) in cervical cancer.
Gupta MK et al.
Journal of Cancer Research and Clinical Oncology, 2023
Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
Lee K et al.
Scientific Reports, 2023
Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.
Reyes-González J et al.
Neuro-oncology, 2023
Association of human telomerase reverse transcriptase promoter mutation with unfavorable prognosis in glioma: A systematic review and meta-analysis.
Hua R et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences, 2023
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
Heo J et al.
Plos One, 2023
Genetic susceptibility of bladder cancer in the Lebanese population.
Kourie HR et al.
Bmc Medical Genomics, 2022
Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances.
Hasanau T et al.
Biomedicines, 2022
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study.
Moitra P et al.
Journal of Neuro-oncology, 2022
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Lee H et al.
Cancer Research and Treatment, 2022
Gene polymorphisms and prognosis of head and neck squamous cell carcinoma: a systematic review.
Rajabi-Moghaddam M et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2022
Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review.
Rajabi-Moghaddam M et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2022
Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
Hoxhaj I et al.
Bmc Cancer, 2021
Pathological characteristics, survival, and risk of breast cancer associated with estrogen and xenobiotic metabolism polymorphisms in Mexican women with breast cancer.
Martínez-Ramírez OC et al.
Cancer Causes & Control : Ccc, 2021
Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines.
Bai H et al.
Biomed Research International, 2021
Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer.
Montazeri Z et al.
Gut, 2020
The Role of O6-methylguanine-DNA Methyltransferase Polymorphisms in Prostate Cancer Susceptibility: a Meta-Analysis.
Zhang W et al.
Pathology Oncology Research : Por, 2020
Association of DNA repair gene polymorphisms with colorectal cancer risk and treatment outcomes.
Al-Shaheri FN et al.
Experimental and Molecular Pathology, 2020
Cumulative Evidence for Associations between Genetic Variants and Risk of Esophageal Cancer.
Li G et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2020
Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).
Kewitz-Hempel S et al.
Molecular Imaging and Biology, 2019
Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas.
Bettegowda C et al.
Neuro-oncology, 2019
Systematic Review of Genetic Factors in the Etiology of Esophageal Squamous Cell Carcinoma in African Populations.
Simba H et al.
Frontiers in Genetics, 2019
TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study.
Juratli TA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2018
The potential role of MGMT rs12917 polymorphism in cancer risk: an updated pooling analysis with 21010 cases and 34018 controls.
Sheng Z et al.
Bioscience Reports, 2018
Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSα interaction.
Fang J et al.
Proceedings of the National Academy of Sciences of the United States of America, 2018
Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Lee JH et al.
Nature, 2018
The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis.
Kiczmer P et al.
Acta Biochimica Polonica, 2018
Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.
Liu C et al.
Lung Cancer (amsterdam, Netherlands), 2017
MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case.
Altinoz MA et al.
Journal of Chemotherapy (florence, Italy), 2017
The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer.
Laczmanska I et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2017
Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C et al.
Bmc Cancer, 2017
Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in Glioblastoma.
Schulze Heuling E et al.
Molecular Cancer Research : Mcr, 2017
Genetic and epigenetic stability of oligodendrogliomas at recurrence.
Aihara K et al.
Acta Neuropathologica Communications, 2017
The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.
Hsu CY et al.
Plos One, 2017
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U et al.
Journal of Neuro-oncology, 2016
Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.
Lombardi G et al.
American Journal of Clinical Oncology, 2015
Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk.
Wang H et al.
Medicine, 2015
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.
Mosrati MA et al.
Oncotarget, 2015
Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer.
McCullough LE et al.
Annals of Epidemiology, 2015